Related Experiment Videos
Behçet's disease in Japan and in Great Britain: a comparative study
M Muhaya1, S Lightman, E Ikeda
1Department of Clinical Ophthalmology, Moorfields Eye Hospital, Institute of Ophthalmology, London, UK.
Ocular Immunology and Inflammation
|December 20, 2000
Summary
This study found significant differences in Behçet
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Behçet's disease (BD) is a global cause of visual impairment with ethnic variations.
- Current therapeutic strategies for acute intraocular inflammation in BD have unknown long-term visual outcomes and ethnic efficacy.
- Understanding these differences is crucial for optimizing patient care.
Purpose of the Study:
- To compare ocular manifestations and treatment strategies for Behçet's disease between Japanese and UK patient cohorts.
- To investigate potential ethnic differences in the long-term visual outcomes of Behçet's disease.
- To evaluate the efficacy of current therapeutic management in different ethnic groups.
Main Methods:
- A comparative study was conducted on patients diagnosed with Behçet's disease at Moorfields Eye Hospital (London) and Kurume University School of Medicine (Japan).
- Patient demographics, clinical ocular features, inflammatory scores, and current therapies were analyzed.
- International Study Group criteria for Behçet's disease and the Behçet's Disease Research Committee of Japan criteria were used for diagnosis.
Main Results:
- Japanese patients were older and had a higher incidence of active anterior and posterior uveitis compared to London patients.
- No significant differences were observed in the duration of systemic disease, affected systems, or the presence of optic atrophy.
- Treatment regimens differed significantly, with more topical steroid use in Japan and more systemic steroid use in London; more surgeries for cataract and glaucoma were performed in Japan.
Conclusions:
- Ethnic variations exist in the presentation and management of Behçet's disease, particularly concerning intraocular inflammation.
- Current treatment strategies may not be universally effective across different ethnic groups.
- Further research is needed to elucidate the long-term visual outcomes and optimize therapies for diverse populations affected by Behçet's disease.